Transcription of Model Standing Order and Immunization Protocol Template
{{id}} {{{paragraph}}}
IP COVID-19 Vaccine Page 1 of 19 OHA 8285 (7/19) A. PUBLIC HEALTH DIVISION Immunization Program Immunization Protocol COVID-19 Vaccine (Pfizer-BioNTech, Moderna, Janssen [Johnson & Johnson]) Last Reviewed 7 January 2022 Last Revised 7 January 2022 This Order expires 30 June 2022 Table of contents What s new .. 1 Oregon Immunization Protocol .. 2 Vaccine schedule for COVID-19 Vaccine .. 3 Licensed COVID-19 vaccine .. 4 Recommendations for use .. 5 Contraindications .. 6 Warnings and precautions .. 7 Other considerations .. 8 Side effects and adverse reactions .. 9 Storage and handling .. 9 Adverse events reporting .. 11 References .. 12 Appendix A .. 15 Appendix B .. 16 Appendix C .. 17 Appendix D.
regardless of immunocompetenc y status. 9. E. For healthy patients 12–64 years of age and especially for males ages 12– 39 years of age, an 8-week interval may be optimal to balance disease protection and vaccine risk. Adults ≥65 years of age, patients who are immunocompromised, and others who need rapid protection should continue to
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}